Krystal Biotech (KRYS) call put ratio 1 call to 2.9 puts as shares rally 119% after data release

Krystal Biotech (NASDAQ: KRYS) 30-day option implied volatility is at 131; compared to its 52-week range of 45 to 325 after topline data expected from the pivotal GEM-3 trial evaluating B-VEC. Call put ratio 1 call to 2.9 puts as shares rally 119%.

You May Also Be Interested In

• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%
• NewAmsterdam Pharma (NAMS) call put ratio 1 call to 4.8 puts with a focus on 2K contracts of January 25 puts
• Amer Sports (AS) call put ratio 6.4 calls to 1 put with a focus on 4700 contracts of September 45 calls